{"transactions":[{"id":3683578,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-29T23:57:09.000Z","date":"2019-01-25","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2019 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":90000,"derivative":{"exercise_price":16.85,"expiration_date":"2029-01-24","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001567619-19-001863","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761919001863/doc1.xml","form_type":"4"}},{"id":3730363,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-12-14T20:23:04.000Z","date":"2018-12-12","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":7220,"derivative":{"exercise_price":1.4489,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-18-008005","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918008005/doc1.xml","form_type":"4"}},{"id":3730362,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-14T20:23:04.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":3000,"price":15,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001567619-18-008005","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918008005/doc1.xml","form_type":"4"}},{"id":3730361,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-14T20:23:04.000Z","date":"2018-12-12","kind":"exercise","acquired":true,"shares":3000,"price":1.4489,"value":4346.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001567619-18-008005","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918008005/doc1.xml","form_type":"4"}},{"id":3773995,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-05T21:15:24.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":10220,"derivative":{"exercise_price":1.4489,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-18-005082","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005082/doc1.xml","form_type":"4"}},{"id":3773994,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-05T21:15:24.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":3000,"price":15,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001567619-18-005082","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005082/doc1.xml","form_type":"4"}},{"id":3773993,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-05T21:15:24.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":3000,"price":1.4489,"value":4346.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001567619-18-005082","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918005082/doc1.xml","form_type":"4"}},{"id":3800690,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-02T19:18:34.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":13220,"derivative":{"exercise_price":1.4489,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-18-003477","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918003477/doc1.xml","form_type":"4"}},{"id":3800689,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-02T19:18:34.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":3000,"price":18.46,"value":55380.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001567619-18-003477","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918003477/doc1.xml","form_type":"4"}},{"id":3800688,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-02T19:18:34.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":3000,"price":1.4489,"value":4346.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001567619-18-003477","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918003477/doc1.xml","form_type":"4"}},{"id":3823072,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-06T23:18:15.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":16220,"derivative":{"exercise_price":1.4489,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001567619-18-002232","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918002232/doc1.xml","form_type":"4"}},{"id":3823071,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-06T23:18:15.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":3000,"price":22.39,"value":67170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001567619-18-002232","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918002232/doc1.xml","form_type":"4"}},{"id":3823070,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-09-06T23:18:15.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":3000,"price":1.4489,"value":4346.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001567619-18-002232","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000156761918002232/doc1.xml","form_type":"4"}},{"id":3854733,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-03T00:55:14.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":19220,"derivative":{"exercise_price":1.4489,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":290},"source":{"system":"sec-edgar","filing":"0001140361-18-035277","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/doc1.xml","form_type":"4"}},{"id":3854732,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-08-03T00:55:14.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":2710,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":2710},"source":{"system":"sec-edgar","filing":"0001140361-18-035277","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/doc1.xml","form_type":"4"}},{"id":3854731,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-03T00:55:14.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":3000,"price":26.05,"value":78150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001140361-18-035277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/doc1.xml","form_type":"4"}},{"id":3854730,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-03T00:55:14.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":290,"price":1.4489,"value":420.181,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001140361-18-035277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/doc1.xml","form_type":"4"}},{"id":3854729,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-03T00:55:14.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":2710,"price":1.2599,"value":3414.329,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8638,"source":{"system":"sec-edgar","filing":"0001140361-18-035277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118035277/doc1.xml","form_type":"4"}},{"id":3874117,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-03T22:51:27.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":2710,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-18-031328","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031328/doc1.xml","form_type":"4"}},{"id":3874116,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-03T22:51:27.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":3000,"price":22.56,"value":67680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001140361-18-031328","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031328/doc1.xml","form_type":"4"}},{"id":3874115,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-03T22:51:27.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":3000,"price":1.2599,"value":3779.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001140361-18-031328","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118031328/doc1.xml","form_type":"4"}},{"id":3904517,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-05T23:46:45.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":5710,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-18-027475","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118027475/doc1.xml","form_type":"4"}},{"id":3904516,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-05T23:46:45.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":3000,"price":25.931,"value":77793.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $25.75 to $26.25, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares were acquired under the issuer's Employee Stock Purchase Plan on May 31, 2018."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001140361-18-027475","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118027475/doc1.xml","form_type":"4"}},{"id":3904515,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-05T23:46:45.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":3000,"price":1.2599,"value":3779.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":8928,"source":{"system":"sec-edgar","filing":"0001140361-18-027475","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118027475/doc1.xml","form_type":"4"}},{"id":3904514,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-06-05T23:46:45.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":1187,"price":17.901,"value":21248.487,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were acquired under the issuer's Employee Stock Purchase Plan on May 31, 2018."}],"balance_after":5928,"source":{"system":"sec-edgar","filing":"0001140361-18-027475","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118027475/doc1.xml","form_type":"4"}},{"id":3949509,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-02T22:26:28.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":8710,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-18-021345","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118021345/doc1.xml","form_type":"4"}},{"id":3949508,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-02T22:26:28.000Z","date":"2018-05-01","kind":"sale","acquired":false,"shares":3000,"price":26.5207,"value":79562.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $26.22 to $26.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4741,"source":{"system":"sec-edgar","filing":"0001140361-18-021345","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118021345/doc1.xml","form_type":"4"}},{"id":3949507,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-02T22:26:28.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":3000,"price":1.2599,"value":3779.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":7741,"source":{"system":"sec-edgar","filing":"0001140361-18-021345","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118021345/doc1.xml","form_type":"4"}},{"id":3969135,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-04T18:27:36.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":11710,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001140361-18-016993","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118016993/doc1.xml","form_type":"4"}},{"id":3969134,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-04T18:27:36.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":3000,"price":28.12,"value":84360.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":4741,"source":{"system":"sec-edgar","filing":"0001140361-18-016993","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118016993/doc1.xml","form_type":"4"}},{"id":3969133,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-04T18:27:36.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":3000,"price":1.2599,"value":3779.7,"ownership":{"direct":true},"balance_after":7741,"source":{"system":"sec-edgar","filing":"0001140361-18-016993","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118016993/doc1.xml","form_type":"4"}},{"id":4013967,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":14485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":20000,"derivative":{"exercise_price":1.1339,"expiration_date":"2021-09-13","underlying":"Common Stock","underlying_shares":14485},"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013966,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"exercise","acquired":false,"shares":5515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":14710,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":5515},"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013965,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"100% of the shares subject to the option are fully vested and exercisable."}],"balance_after":20225,"derivative":{"exercise_price":1.2599,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013964,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":1944,"price":31.015,"value":60293.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $31.00 to $31.09, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4741,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013963,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":12541,"price":30.411,"value":381384.351,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":6685,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013962,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"exercise","acquired":true,"shares":14485,"price":1.1339,"value":16424.5415,"ownership":{"direct":true},"balance_after":19226,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013961,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"sale","acquired":false,"shares":5515,"price":30.059,"value":165775.385,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4741,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013960,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-02","kind":"exercise","acquired":true,"shares":5515,"price":1.2599,"value":6948.3485,"ownership":{"direct":true},"balance_after":10256,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013959,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":13000,"price":29.4032,"value":382241.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.81, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4741,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4013958,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T21:56:22.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":13000,"price":1.2599,"value":16378.7,"ownership":{"direct":true},"balance_after":17741,"source":{"system":"sec-edgar","filing":"0001140361-18-012009","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118012009/doc1.xml","form_type":"4"}},{"id":4078627,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-03T00:28:52.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":2548,"price":26.6915,"value":68009.942,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.39 to $27.19, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":4741,"source":{"system":"sec-edgar","filing":"0001140361-18-004851","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118004851/doc1.xml","form_type":"4"}},{"id":4087929,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-26T19:55:36.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2018 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date."}],"balance_after":100000,"derivative":{"exercise_price":25.82,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001140361-18-003376","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118003376/doc1.xml","form_type":"4"}},{"id":4110570,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T20:23:18.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":2500,"price":21.11,"value":52775.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":7289,"source":{"system":"sec-edgar","filing":"0001140361-18-000410","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036118000410/doc1.xml","form_type":"4"}},{"id":4141508,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-05T17:56:27.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":2500,"price":20.58,"value":51450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":9789,"source":{"system":"sec-edgar","filing":"0001140361-17-045018","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117045018/doc1.xml","form_type":"4"}},{"id":4141507,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-12-05T17:56:27.000Z","date":"2017-11-30","kind":"grant","acquired":true,"shares":163,"price":12.1465,"value":1979.8795,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"163 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":12289,"source":{"system":"sec-edgar","filing":"0001140361-17-045018","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117045018/doc1.xml","form_type":"4"}},{"id":4172403,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-11-03T20:33:24.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":2500,"price":20,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":12126,"source":{"system":"sec-edgar","filing":"0001140361-17-040975","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117040975/doc1.xml","form_type":"4"}},{"id":4191768,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-10-04T16:38:20.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":2500,"price":18.1,"value":45250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":14626,"source":{"system":"sec-edgar","filing":"0001140361-17-037554","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117037554/doc1.xml","form_type":"4"}},{"id":4217535,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-09-05T22:18:27.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":2500,"price":17.17,"value":42925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":17126,"source":{"system":"sec-edgar","filing":"0001140361-17-034349","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117034349/doc1.xml","form_type":"4"}},{"id":4236331,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-08-11T16:51:06.000Z","date":"2017-08-09","kind":"sale","acquired":false,"shares":2500,"price":15,"value":37500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":19626,"source":{"system":"sec-edgar","filing":"0001140361-17-031316","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117031316/doc1.xml","form_type":"4"}},{"id":4261496,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-06T15:20:16.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":2500,"price":15.47,"value":38675.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":22126,"source":{"system":"sec-edgar","filing":"0001140361-17-027295","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117027295/doc1.xml","form_type":"4"}},{"id":4295234,"issuer":{"id":5124,"kind":"organization","name":"CytomX Therapeutics, Inc."},"owners":[{"id":160800,"kind":"person","name":"RAY DEBANJAN","position":1,"cik":"0001706863","reported_name":"RAY DEBANJAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-02T19:40:10.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":2698,"price":8.6785,"value":23414.593,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,698 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":24626,"source":{"system":"sec-edgar","filing":"0001140361-17-023528","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501989/000114036117023528/doc1.xml","form_type":"4"}}]}